BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32768742)

  • 1. Design, synthesis and biological evaluation of imidazolidine-2,4-dione and 2-thioxothiazolidin-4-one derivatives as lymphoid-specific tyrosine phosphatase inhibitors.
    Liang X; Fu H; Xiao P; Fang H; Hou X
    Bioorg Chem; 2020 Oct; 103():104124. PubMed ID: 32768742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a novel submicromolar inhibitor of the lymphoid specific tyrosine phosphatase.
    Xie Y; Liu Y; Gong G; Rinderspacher A; Deng SX; Smith DH; Toebben U; Tzilianos E; Branden L; Vidović D; Chung C; Schürer S; Tautz L; Landry DW
    Bioorg Med Chem Lett; 2008 May; 18(9):2840-4. PubMed ID: 18434147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and structure-function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22.
    Li K; Hou X; Li R; Bi W; Yang F; Chen X; Xiao P; Liu T; Lu T; Zhou Y; Tian Z; Shen Y; Zhang Y; Wang J; Fang H; Sun J; Yu X
    J Biol Chem; 2019 May; 294(21):8653-8663. PubMed ID: 30979725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast identification of novel lymphoid tyrosine phosphatase inhibitors using target-ligand interaction-based virtual screening.
    Hou X; Li R; Li K; Yu X; Sun JP; Fang H
    J Med Chem; 2014 Nov; 57(22):9309-22. PubMed ID: 25372368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological evaluation and 3D-QSAR studies of imidazolidine-2,4-dione derivatives as novel protein tyrosine phosphatase 1B inhibitors.
    Wang MY; Jin YY; Wei HY; Zhang LS; Sun SX; Chen XB; Dong WL; Xu WR; Cheng XC; Wang RL
    Eur J Med Chem; 2015 Oct; 103():91-104. PubMed ID: 26342135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiuram disulfides as pseudo-irreversible inhibitors of lymphoid tyrosine phosphatase.
    Kulkarni RA; Stanford SM; Vellore NA; Krishnamurthy D; Bliss MR; Baron R; Bottini N; Barrios AM
    ChemMedChem; 2013 Sep; 8(9):1561-8. PubMed ID: 23873737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.
    Yu X; Sun JP; He Y; Guo X; Liu S; Zhou B; Hudmon A; Zhang ZY
    Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19767-72. PubMed ID: 18056643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Flexibility in Docking-Based Virtual Screening: Discovery of Novel Lymphoid-Specific Tyrosine Phosphatase Inhibitors Using Multiple Crystal Structures.
    Hou X; Li K; Yu X; Sun JP; Fang H
    J Chem Inf Model; 2015 Sep; 55(9):1973-83. PubMed ID: 26360643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of imidazolidine-2,4-dione derivatives as selective inhibitors by targeting protein tyrosine phosphatase-1B over T-cell protein tyrosine phosphatase.
    Ma Y; Sun SX; Cheng XC; Wang SQ; Dong WL; Wang RL; Xu WR
    Chem Biol Drug Des; 2013 Nov; 82(5):595-602. PubMed ID: 23848232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoid-specific tyrosine phosphatase (Lyp): a potential drug target for treatment of autoimmune diseases.
    Du J; Qiao Y; Sun L; Wang X
    Curr Drug Targets; 2014 Mar; 15(3):335-46. PubMed ID: 24188455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lymphoid tyrosine phosphatase by benzofuran salicylic acids.
    Vang T; Xie Y; Liu WH; Vidović D; Liu Y; Wu S; Smith DH; Rinderspacher A; Chung C; Gong G; Mustelin T; Landry DW; Rickert RC; Schürer SC; Deng SX; Tautz L
    J Med Chem; 2011 Jan; 54(2):562-71. PubMed ID: 21190368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold(I) phosphine mediated selective inhibition of lymphoid tyrosine phosphatase.
    Karver MR; Krishnamurthy D; Bottini N; Barrios AM
    J Inorg Biochem; 2010 Mar; 104(3):268-73. PubMed ID: 20083307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct functional and conformational states of the human lymphoid tyrosine phosphatase catalytic domain can be targeted by choice of the inhibitor chemotype.
    Vidović D; Xie Y; Rinderspacher A; Deng SX; Landry DW; Chung C; Smith DH; Tautz L; Schürer SC
    J Comput Aided Mol Des; 2011 Sep; 25(9):873-83. PubMed ID: 21904909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalent inhibition of the lymphoid tyrosine phosphatase.
    Ahmed VF; Bottini N; Barrios AM
    ChemMedChem; 2014 Feb; 9(2):296-9. PubMed ID: 24403103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of new potent PTP1B inhibitors with the skeleton of 2-substituted imino-3-substituted-5-heteroarylidene-1,3-thiazolidine-4-one: Part I.
    Meng G; Zheng M; Wang M; Tong J; Ge W; Zhang J; Zheng A; Li J; Gao L; Li J
    Eur J Med Chem; 2016 Oct; 122():756-769. PubMed ID: 27526040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, biological evaluation and molecular dynamics simulation studies of imidazolidine-2,4-dione derivatives as novel PTP1B inhibitors.
    Ma Y; Ding TT; Liu YY; Zheng ZH; Sun SX; Zhang LS; Zhang H; Lu XH; Cheng XC; Wang RL
    Biochem Biophys Res Commun; 2021 Nov; 579():40-46. PubMed ID: 34583194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitors.
    Liang T; Xue J; Yao Z; Ye Y; Yang X; Hou X; Fang H
    Eur J Med Chem; 2021 Oct; 221():113526. PubMed ID: 33992929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B.
    Ottanà R; Paoli P; Lori G; Adornato I; Previti S; Naß A; Wolber G; Maccari R
    Bioorg Chem; 2019 Nov; 92():103211. PubMed ID: 31491569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of novel 5-((substituted quinolin-3-yl/1-naphthyl) methylene)-3-substituted imidazolidin-2,4-dione as HIV-1 fusion inhibitors.
    Ibrahim TS; Bokhtia RM; Al-Mahmoudy AMM; Taher ES; AlAwadh MA; Elagawany M; Abdel-Aal EH; Panda S; Gouda AM; Asfour HZ; Alhakamy NA; Youssif BGM
    Bioorg Chem; 2020 Jun; 99():103782. PubMed ID: 32229348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target-specific control of lymphoid-specific protein tyrosine phosphatase (Lyp) activity.
    Walton ZE; Bishop AC
    Bioorg Med Chem; 2010 Jul; 18(14):4884-91. PubMed ID: 20594861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.